News | Cardiovascular Business | August 17, 2022

Memorial Cardiac and Vascular Institute Adds Cardiologists to its Physician Roster

Memorial Healthcare System, a South Florida-based academic medical center, has added a diverse trio of doctors to its cardiac care team. 

Adetola Ladejobi, MD

Adetola Ladejobi, MD 


August 17, 2022 — Memorial Healthcare System, a South Florida-based academic medical center, has added a diverse trio of cardiologists to its cardiac care team. The fellowship-trained physicians have all worked internationally during their medical careers and join Memorial Cardiac and Vascular Institute as it grows its research and academic programs. 

Adetola Ladejobi, MD, an electrophysiologist, comes to Memorial from the Mayo Clinic, where he completed two fellowships and was an instructor at its college of medicine. Dr. Ladejobi is focused on patient care, research, quality improvement, and healthcare operations. A native of Nigeria, “Tola” earned a master’s degree in public health from Harvard University and has also worked as a strategic consultant to healthcare systems, insurance companies, and Fortune 100 companies. 

Lynda Otalvaro, MD, a clinical cardiologist, was most recently at the University of Florida where she was an assistant professor at UF’s College of Medicine and director of its Lipid Clinic. In the time prior to that, Dr. Otalvaro worked as an adult non-invasive cardiologist in Kentucky. She finished first in her class at Universidad Libre, School of Medicine in Cali, Colombia before coming to the University of Miami’s Miller School of Medicine. While at UM, Dr. Otalvaro completed an internal medicine residency and fellowship in cardiology. 

Sarah Rosanel, MD, completed both an internal medicine residency and cardiovascular disease fellowship at Maimonides Medical Center in Brooklyn, NY. A clinical cardiologist, Dr. Rosanel earned degrees from the Israel Institute of Technology’s Technion American Medical School and Yeshiva University in New York. 

“The capabilities, accomplishments, and diverse backgrounds of these physicians will
enhance Memorial’s offerings as an academic medical center, on par with larger, university-based systems,” said Dr. Michael Cortelli, chief of the Memorial Cardiac and Vascular Institute. “Their clinical, research, and academic expertise will benefit our patients and doctors alike.” 

Memorial’s Cardiac & Vascular Institute is a cardiovascular care leader, offering a wide array of services dedicated to the prevention, detection, and treatment of cardiovascular disease. Its multi-disciplinary specialists collaborate using sophisticated diagnostic equipment and facilities. Physician-review panels and nurses regularly review cardiovascular care outcomes to ensure quality assurance that utilizes computerized data collection. 

With extraordinary medical expertise, advanced technology and exacting quality guidelines, Memorial Cardiac & Vascular Institute offers a superior level of cardiovascular care. 

For more information: https://www.mhs.net/ 


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now